Regulation of arginine vasopressin in the human heart.
BACKGROUND
The role of arginine vasopressin (AVP) in the heart has yet to be determined. The present study was designed to examine whether AVP is regulated in the human heart.


RESULTS
The subjects were 93 patients who underwent coronary angiography and left ventriculography. Blood samples were collected at the aortic root (AO) and the coronary sinus (CS) to measure the plasma levels of AVP. The patients who showed increases in AVP levels at the CS and AO were assigned to the increased AVP group and those who showed no change or a decrease were assigned to the non-increased AVP group. Cardiac function was compared between these 2 groups. There was a significant difference (p<0.0234) in left ventricular end-diastolic volume index between the increased AVP group (125.5 +/-53.4 ml/m2) and the non-increased AVP group (102.2+/-30.6 ml/m2). There was also a significant difference (p<0.0137) in left ventricular stroke volume index between the increased AVP group (66.6+/-23.2 ml/m2) and the non-increased AVP group (54.4+/-18.6 ml/m2).


CONCLUSIONS
These results suggest that both the production of AVP and synthesis with its receptors may be enhanced at regional sites of the human heart in the volume load.
Watanabe
Ikuyoshi
I
Division of Cardiovascular Medicine, Surugadai Nihon University Hospital, Tokyo, Japan. ikuwata@med.nihon-u.ac.jp
Tani
Shigemasa
S
Nagao
Ken
K
Anazawa
Takeo
T
Kawamata
Hirofumi
H
Ohguchi
Sumito
S
Kanmatsuse
Katsuo
K
Kushiro
Toshio
T
D000368:Aged; D001127:Arginine Vasopressin / Q000097:blood*; D017023:Coronary Angiography / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000000981:diagnostic imaging / Q000188:drug therapy; D009206:Myocardium / Q000378:metabolism*; D013318:Stroke Volume
D001127:Arginine Vasopressin